US biopharmaceutical finance and the sustainability of the biotech business model
Year of publication: |
2011
|
---|---|
Authors: | Lazonick, William ; Tulum, Öner |
Published in: |
Research policy : policy, management and economic studies of science, technology and innovation. - Amsterdam [u.a.] : Elsevier, ISSN 0048-7333, ZDB-ID 121149-3. - Vol. 40.2011, 9, p. 1170-1187
|
Subject: | Biotechnologie-Industrie | Biotechnology industry | Pharmakologie | Pharmacology | Forschungsfinanzierung | Research funding | Corporate Governance | Corporate governance | Shareholder Value | Shareholder value | USA | United States |
-
Medical innovation and government intervention : reconciling interests to create stakeholder value
Hermans, Raine, (2009)
-
Grewal, Rajdeep, (2008)
-
Financing life science innovation : venture capital, corporate governance and commercialization
Styhre, Alexander, (2015)
- More ...
-
US Biopharmaceutical Finance and the Sustainability of the Biotech Boom
Lazonick, William, (2010)
-
Apple's changing business model : what should the world's richest company do with all those profits?
Lazonick, William, (2013)
-
Apple's Changing Business Model : What Should the World's Richest Company Do with All Those Profits?
Lazonick, William, (2016)
- More ...